2

Correlation of PVT1 and miR-214 expression with clinicopathologic characteristics of EOC patients

Characteristics	n	PVT1 expression, n		P	MiR-214 expression, n		P
Characteristics	n	Low	High	P	Low	High	P
Age (years)				0.679			0.885
≤51	136	61	75		76	60
>51	95	40	55		54	41
Menopause				0.302			0.453
Yes	154	71	83		84	70
No	77	30	47		46	31
Pathologic type				0.940			0.129
Serous	116	51	65		71	45
Mucous and others*	115	50	65		59	56
Histologic grade				0.924			<0.001
G1–2	141	62	79		63	78
G3	90	39	51		67	23
FIGO stage				<0.001			<0.001
I–II	81	53	28		29	52
III–IV	150	48	102		101	49
LN metastasis				0.436			0.266
No	186	79	107		108	78
Yes	45	22	23		22	23
Residual tumor (cm)				0.552			0.204
<1	187	80	107		109	78
≥ 1	44	21	23		21	23
Ascites volume (mL)				0.216			0.232
≤1000	157	73	84		83	72
>1000	74	28	46		47	29
Serum CA125 (U/mL)				0.548			0.831
≤675	140	59	81		78	62
>675	91	42	49		52	39

*Others: others include the endometrioid, clear cell, and undifferentiated ovarian cancers.